Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Protecting the US from bio-threats: a public-private approach

Mid-way through 2012 and it’s easy to feel that the United States (US) Government has stopped taking bio-security seriously. The Obama administration’s reluctance to deal with the issue has received widespread criticism but, as Dr Nicola Davies discovers, the establishment of three dedicated new centres alongside pharma giants Emergent Biosolutions, GSK and Novartis could signal a more practical approach to active bio-defence.

Free download worth over $5000
Download our 2018 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global technology, media and telecoms

Go Top